Javascript must be enabled to continue!
Immunoinformatics Prediction of Epitope Based Peptide Vaccine Against Madurella mycetomatis Translationally Controlled Tumor Protein
View through CrossRef
Abstract
Background
Madurella. mycetomatis
is most common causative agent of mycetoma in Sudan and worldwide. No vaccines are available till now so design of effective vaccine is essential as protection tool. Peptide vaccine can overcome the common side effects of the conventional vaccines. The aim of this study was to design peptide based vaccine for
M.Mycetomatis Translationally Controlled Tumor Protein (TCTP)
using immunoinformatics tools.
Materials and methods
TCTP
sequences were retrieved from NCBI and then processed using BioEdit program to determine conserved regions and different immunoinformatics tools from IEDB. Population coverage analysis was performed for the most promising epitopes. Homology modelling was performed to show their structural positions in
TCTP.
Protein analysis was done using Expasy (ProtParamsotware).
Results and conclusion
Four epitopes passed the Bepipred, Emini, Kolaskar and Tongaonkar tools. 111 epitopes were predicted to interact with MHCI alleles with IC50 < 500 nM, three of them were most promising. 274 predicted epitopes were interacted with MHCII alleles with IC50 < 100 nM, four of them were most promising. The epitope (YMKSVKKAL) was the most promising one concerning its binding with MHCI alleles, while (FRLQSTSFD) was the most promising for MHC II. The epitope (YLKAYMKSV) is shared betweenMHC I and II. For the population coverage of
M. Mycetomatis TCTP
vaccine Sudan (90.39%) had the highest percentage for MHC I. This is the first computational vaccinology study conducted in mycetoma caused by
M. Mycetomatis
using
TCTP.
Title: Immunoinformatics Prediction of Epitope Based Peptide Vaccine Against
Madurella mycetomatis Translationally Controlled Tumor Protein
Description:
Abstract
Background
Madurella.
mycetomatis
is most common causative agent of mycetoma in Sudan and worldwide.
No vaccines are available till now so design of effective vaccine is essential as protection tool.
Peptide vaccine can overcome the common side effects of the conventional vaccines.
The aim of this study was to design peptide based vaccine for
M.
Mycetomatis Translationally Controlled Tumor Protein (TCTP)
using immunoinformatics tools.
Materials and methods
TCTP
sequences were retrieved from NCBI and then processed using BioEdit program to determine conserved regions and different immunoinformatics tools from IEDB.
Population coverage analysis was performed for the most promising epitopes.
Homology modelling was performed to show their structural positions in
TCTP.
Protein analysis was done using Expasy (ProtParamsotware).
Results and conclusion
Four epitopes passed the Bepipred, Emini, Kolaskar and Tongaonkar tools.
111 epitopes were predicted to interact with MHCI alleles with IC50 < 500 nM, three of them were most promising.
274 predicted epitopes were interacted with MHCII alleles with IC50 < 100 nM, four of them were most promising.
The epitope (YMKSVKKAL) was the most promising one concerning its binding with MHCI alleles, while (FRLQSTSFD) was the most promising for MHC II.
The epitope (YLKAYMKSV) is shared betweenMHC I and II.
For the population coverage of
M.
Mycetomatis TCTP
vaccine Sudan (90.
39%) had the highest percentage for MHC I.
This is the first computational vaccinology study conducted in mycetoma caused by
M.
Mycetomatis
using
TCTP.
Related Results
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations
Background/Objectives: Eumycetoma, caused by Madurella mycetomatis, is a chronic fungal infection with limited treatment options and increasing drug resistance. CYP51, a key enzyme...
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors
Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors
Eumycetoma, a chronic fungal infection caused by Madurella mycetomatis, is a neglected tropical disease characterized by tumor-like growths that can lead to permanent disability an...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Immunoinformatic Approaches to Explore Monkeypox Virus to Design B and T Cell Multi-epitope Subunit Vaccine
Immunoinformatic Approaches to Explore Monkeypox Virus to Design B and T Cell Multi-epitope Subunit Vaccine
Background: Monkeypox virus (MPXV), a member of the Orthopoxvirus genus, is closely related to the variola and vaccinia viruses and has emerged as a significant global public healt...
Translationally Controlled Tumor Protein
TCTP
as Peptide Vaccine against
Schistosoma japonicum
: an Immunoinformatics Approach
Translationally Controlled Tumor Protein
TCTP
as Peptide Vaccine against
Schistosoma japonicum
: an Immunoinformatics Approach
Abstract
Schistosoma japonicum is the most pathogenic causative form of schistosomiasis that causes a major health problem in its endemic countri...
Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins
Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins
Human papillomavirus type 16 (HPV16) infection is responsible for more than 50% of global cervical cancer cases. The development of a vaccine based on cytotoxic T-lymphocyte (CTL) ...

